Table 1.
Palonosetron group, n = 35 | Granisetron group, n = 35 | Ramosetron group, n = 35 | P-value | |
---|---|---|---|---|
Age, year | 51.5 ± 16.3 | 52.5 ± 15.7 | 48.2 ± 12.1 | 0.42 |
Height (cm) | 155.3 ± 3.1 | 157.1 ± 6.1 | 157.2 ± 3.3 | 0.65 |
Weight (kg) | 60.1 ± 4.9 | 59.3 ± 5.1 | 56.3 ± 4.3 | 0.55 |
Operation Time(min) | 100.2 ± 34.1 | 99.4 ± 25.3 | 92.6 ± 24.9 | 0.46 |
Anesthesia Time(min) | 128.1 ± 47.5 | 123.5 ± 35.1 | 120.1 ± 23.0 | 0.63 |
Fluid Admin(mL) | 522.1 ± 61.2 | 644 ± 33.3 | 538 ± 53.9 | 0.75 |
ASA class I/II | 23/12 | 24/11 | 26/9 | 0.67 |
Comorbid dis. | 0.56 | |||
Hypertension | 7 | 8 | 8 | |
Diabetes | 3 | 3 | 4 | |
Othera | 1 | 0 | 1 |
aOther comorbid diseases include: Fatty liver, Rheumatoid arthritis